CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 1

Electronics and Data, How Effective are Personal Electronics in Helping Patients to Maintain Good Health?

What does the Future Hold for Patients? In Oct 2017 the Adherium stock was trading around AUS $22 with the Rapihaler device FDA approved. Today 2024 – 16 differen...
Continue Reading →
Volume 16 Issue 1

Fighting Counterfeits in the Medical Devices Sector –A Step Beyond the EU MDR

The counterfeiting of health products is a serious and growing concern, and it has come at the forefront of the public mind in recent years with several strict regul...
Continue Reading →
Volume 15 Issue 4

Ensuring a Robust Strategy to Navigate the Development of Challenging APIs

Small molecules as therapeutic agents have played a significant role in the improvement of human health and wellbeing since the discovery and commercialisation of mo...
Continue Reading →
Volume 15 Issue 4

The Power of a Digital-first Lab Transformation: Enhancing Efficiency and Decision-making

The pressing need to respond to global health crises and provide timely access to treatments is driving demand for accelerated speed in bringing new medicines, vacci...
Continue Reading →
Volume 15 Issue 3

Promising Advances in Plasma Proteomics for Early Disease Detection and Personalised Treatments

The early detection of disease poses a substantial challenge in the field of human health, necessitating the development of more accurate biomarkers, enhanced patien...
Continue Reading →
Volume 15 Issue 2

Vaccine Regulation in India

Vaccines are the most important health intervention. Vaccination stimulates the immune system to identify and battle invaders such as viruses or bacteria. A vaccinat...
Continue Reading →
Volume 15 Issue 2

Individual Device Identification: Coding and Marking for the New Dimension in Patient Health and Safety

Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, includin...
Continue Reading →
Volume 15 Issue 2

Artificial Intelligence is a Core Pillar in the Evolution of Digital Health and Patient-centric Solutions

The US Food & Drug Administration has stated that digital technology is driving a revolution in healthcare. The lines between healthcare delivery and clinical re...
Continue Reading →
Volume 15 Issue 1

Connected Drug Delivery Device Development: Where Are We At?

The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% in the next eight...
Continue Reading →
News

Women’s Health Company to Expand

Cervical cancer if not caught early in the precancerous stage can be deadly. Approximately 250,000 women die each year around the world due to the disease, according...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026